Gut microbiome research: revealing the pathological mechanisms and treatment strategies of type 2 diabetes
Fang X, Zhang Y, Huang X, et al.
Diabetes Obes Metab. Pub. online 15 Apr 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Comparative efficacy and safety of pharmacologic therapies for metabolic dysfunction-associated steatotic liver disease over 24 weeks in reducing liver steatosis and fibrosis: a network meta-analysis
Zhong J, Cai Z, Zhu G, Zhang J
Diabetes Obes Metab. Pub. online 10 Apr 2025.
Leggi
Trends in utilization of glucose- and weight-lowering medications after tirzepatide approval in the United States: a population-based cohort study
Ostrominski JW, Ortega-Montiel J, Tesfaye H, et al.
Ann Intern Med. Pub. online 15 Apr 2025.
Leggi
Timing of eating and glycemic control during pregnancy: a systematic review
Boege HL, Park C, Gagnier R, et al.
Nutr Metab Cardiovasc Dis. Pub. online 16 Apr 2025.
Leggi
Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: a retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease
Dunn TJ, Zhu Y, Gronroos NN, et al.
Diabetes Res Clin Pract. 2025:112162.
Leggi
The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy
Tumminia A, Santoro GM, Oteri V, et al.
Diabetes Res Clin Pract. 2025:112173.
Leggi
Pregnancy and postpartum cardiometabolic outcomes among women with overt diabetes compared to women with normoglycaemia, gestational diabetes and pre-existing diabetes: A systematic review and meta-analysis
Pal A, Rawat D, Sadananda S, et al.
Diabetes Obes Metab. Pub. online 11 Apr 2025.
Leggi
The genetics of low and high birthweight and their relationship with cardiometabolic disease
Moen GH, Hwang LD, Brito Nunes C, et al.
Diabetologia. Pub. online 10 Apr 2025.
Leggi
SGLT2 inhibitor use and renal outcomes in low-risk population with diabetes mellitus and normal or low body mass index
Lee YS, Park G, Lee K, et al.
BMJ Open Diabetes Res Care. 2025;13(2):e004876.
Leggi
Association between maternal diabetes and neurodevelopmental outcomes in children: a systematic review and meta-analysis of 202 observational studies comprising 56·1 million pregnancies
Ye W, Luo C, Zhou J, et al.
Lancet Diabetes Endocrinol. Pub. online 7 Apr 2025.
Leggi